Sutro Biopharma (STRO) Capital Expenditures Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) Capital Expenditures Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | 28.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.53% |
| Sep 30, 2025 | 40.14% |
| Jun 30, 2025 | -26.02% |
| Mar 31, 2025 | -68.71% |
| Dec 31, 2024 | -43.12% |
| Sep 30, 2024 | -38.67% |
| Jun 30, 2024 | 10.06% |
| Mar 31, 2024 | -18.00% |
| Dec 31, 2023 | -27.44% |
| Sep 30, 2023 | -40.03% |
| Jun 30, 2023 | -10.98% |
| Mar 31, 2023 | 54.59% |
| Dec 31, 2022 | -98.08% |
| Sep 30, 2022 | -37.92% |
| Jun 30, 2022 | 59.94% |
| Mar 31, 2022 | 140.92% |
| Dec 31, 2021 | 195.30% |
| Sep 30, 2021 | 3.00% |
| Jun 30, 2021 | 160.70% |
| Mar 31, 2021 | 444.91% |